AVITA Medical Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, AVITA Medical stock has a consensus rating of "Buy" and an average price target of $11.04. The average 1-year stock price forecast is 141.05% higher than the current stock price, while the lowest is $7.61 (+66.16%) and the highest is $14.16 (+209.17%).

Price Target: $11.04 (+141.05%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$7.61	$11.04	$11.19	$14.16
Change	+66.16%	+141.05%	+144.32%	+209.17%

Analyst Ratings

The average analyst rating for AVITA Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	2	2	2	2	2	3
Buy	1	0	0	1	1	1
Hold	2	2	2	2	2	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	4	4	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Frank Takkinen Lake Street	Lake Street	Hold → Strong Buy Upgrades $3.5 → $6	Hold → Strong Buy	Upgrades	$3.5 → $6	+31.00%	May 15, 2026
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+118.34%	Apr 9, 2026
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+118.34%	Apr 8, 2026
Carl Byrnes Northland Capital Markets	Northland Capital Markets	Buy Initiates $10	Buy	Initiates	$10	+118.34%	Mar 5, 2026
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+118.34%	Feb 17, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

84.21M

from 71.61M

17.59%

from 71.61M

Revenue Next Year

126.01M

from 84.21M

49.64%

from 84.21M

EPS This Year

-0.89

from -1.74

EPS Next Year

-0.83

from -0.89

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	33.03M	34.42M	50.14M	64.25M	71.61M	84.21M	126.01M
Revenue Growth	12.98%	4.23%	45.68%	28.14%	11.45%	17.59%	49.64%
EPS	-1.03	-1.07	-1.40	-2.39	-1.74	-0.89	-0.83
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	88.9M	263.6M
Avg	84.2M	126.0M
Low	78.9M	88.9M

Revenue Growth

Revenue Growth	2026	2027
High	24.2%	213.1%
Avg	17.6%	49.6%
Low	10.2%	5.6%

EPS Forecast

EPS	2026	2027
High	-0.17	-0.02
Avg	-0.89	-0.83
Low	-1.34	-1.64

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.